Webinar

Cell & Gene Tech Expo offers a live virtual experience designed to empower industry professionals in sourcing best-fit solutions for their cell and gene therapy manufacturing needs. Through this series...

Cell & Gene Tech Expo offers a live virtual experience designed to empower industry professionals in sourcing best-fit solutions for their cell and gene therapy manufacturing needs. Through this series...

Join Univo IRB for a unique educational webinar that takes attendees inside the IRB decision-making process through a live mock board review. Using a fictional agenda item based on real...

The journey from a successful lab result to a reliable, GMP-compliant product is rarely a straight line. It's a transition filled with technical hurdles, regulatory pressure, and the constant challenge...

Unexpected particle findings can raise critical questions about product quality, patient safety, and regulatory compliance. Join KBI Biopharma's experts to learn how clinical in-use studies and advanced particle forensics can...

As biologics developers work to improve productivity, maintain product quality, and accelerate development timelines, traditional optimization approaches can sometimes reach a point of diminishing returns. While cell culture processes generate...

As biologics developers work to improve productivity, reduce development timelines, and manage manufacturing costs, traditional media optimization approaches can become increasingly resource intensive. Predictive modeling is emerging as a complementary...

Nanoparticle programs can stall when early formulation choices fail to hold up through scale-up, tech transfer, and manufacturing. Join leading CDMO experts on August 18 at 11:00 AM ET to...

Oral solid dose programs can run into costly scale-up challenges when early formulation and process decisions aren’t built for long-term manufacturability. Join leading CDMO experts on August 18 at 1:00...

How can life sciences companies developing new medicines engage the FDA successfully during a period of rapid changes in agency personnel and policies? Should companies adjust their agency communication strategies...